Stock Analysis

Analysts Are Updating Their Gerresheimer AG (ETR:GXI) Estimates After Its First-Quarter Results

Gerresheimer AG (ETR:GXI) shareholders are probably feeling a little disappointed, since its shares fell 4.1% to €99.50 in the week after its latest quarterly results. It was a credible result overall, with revenues of €466m and statutory earnings per share of €3.48 both in line with analyst estimates, showing that Gerresheimer is executing in line with expectations. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Gerresheimer after the latest results.

View our latest analysis for Gerresheimer

earnings-and-revenue-growth
XTRA:GXI Earnings and Revenue Growth April 14th 2024

Taking into account the latest results, the current consensus from Gerresheimer's nine analysts is for revenues of €2.13b in 2024. This would reflect a credible 6.6% increase on its revenue over the past 12 months. Statutory earnings per share are predicted to surge 26% to €4.28. Before this earnings report, the analysts had been forecasting revenues of €2.13b and earnings per share (EPS) of €4.23 in 2024. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.

The analysts reconfirmed their price target of €132, showing that the business is executing well and in line with expectations. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. Currently, the most bullish analyst values Gerresheimer at €200 per share, while the most bearish prices it at €115. This is a fairly broad spread of estimates, suggesting that analysts are forecasting a wide range of possible outcomes for the business.

Of course, another way to look at these forecasts is to place them into context against the industry itself. We can infer from the latest estimates that forecasts expect a continuation of Gerresheimer'shistorical trends, as the 8.8% annualised revenue growth to the end of 2024 is roughly in line with the 8.9% annual growth over the past five years. Juxtapose this against our data, which suggests that other companies (with analyst coverage) in the industry are forecast to see their revenues grow 10% per year. So although Gerresheimer is expected to maintain its revenue growth rate, it's only growing at about the rate of the wider industry.

Advertisement

The Bottom Line

The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. They also reconfirmed their revenue estimates, with the company predicted to grow at about the same rate as the wider industry. The consensus price target held steady at €132, with the latest estimates not enough to have an impact on their price targets.

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. At Simply Wall St, we have a full range of analyst estimates for Gerresheimer going out to 2026, and you can see them free on our platform here..

We don't want to rain on the parade too much, but we did also find 1 warning sign for Gerresheimer that you need to be mindful of.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About XTRA:GXI

Gerresheimer

Provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.

Fair value with moderate growth potential.

Advertisement

Weekly Picks

AL
RKLB logo
AlexLovell on Rocket Lab ·

Early mover in a fast growing industry. Likely to experience share price volatility as they scale

Fair Value:US$16.25367.6% overvalued
67 users have followed this narrative
1 users have commented on this narrative
18 users have liked this narrative
AG
Agricola
EXN logo
Agricola on Excellon Resources ·

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Fair Value:CA$31.898.3% undervalued
66 users have followed this narrative
10 users have commented on this narrative
19 users have liked this narrative
FU
FundamentallySarcastic
CCP logo
FundamentallySarcastic on Credit Corp Group ·

Moderation and Stabilisation: HOLD: Fair Price based on a 4-year Cycle is $12.08

Fair Value:AU$12.6410.4% overvalued
11 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative

Updated Narratives

YI
XRAY logo
yiannisz on DENTSPLY SIRONA ·

Dentsply Sirona Stock: Dental Technology Built for Cycles, Not Headlines

Fair Value:US$45.575.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
YI
ETSY logo
yiannisz on Etsy ·

Etsy Stock: Defending Differentiation in a World of Infinite Marketplaces

Fair Value:US$64.4511.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
YI
ALGN logo
yiannisz on Align Technology ·

Align Technology Stock: Premium Orthodontics in a Cost-Sensitive World

Fair Value:US$154.620.9% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

AG
Agricola
EXN logo
Agricola on Excellon Resources ·

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Fair Value:CA$31.898.3% undervalued
66 users have followed this narrative
10 users have commented on this narrative
19 users have liked this narrative
AL
RKLB logo
AlexLovell on Rocket Lab ·

Early mover in a fast growing industry. Likely to experience share price volatility as they scale

Fair Value:US$16.25367.6% overvalued
67 users have followed this narrative
1 users have commented on this narrative
18 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$253.0225.4% undervalued
1015 users have followed this narrative
6 users have commented on this narrative
28 users have liked this narrative